Norberg, H., Westborg, I., & Al-Najjar, A. Eligibility for faricimab in a real-world diabetic macular oedema population: A cross-sectional study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationNorberg, Helena, Inger Westborg, and Ayat Al-Najjar. Eligibility for Faricimab in a Real-world Diabetic Macular Oedema Population: A Cross-sectional Study. BMJ Publishing Group.
MLA (9th ed.) CitationNorberg, Helena, et al. Eligibility for Faricimab in a Real-world Diabetic Macular Oedema Population: A Cross-sectional Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.